| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-06 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-06 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.24 | 4e-05 |